Innovation for Health - 14 February 2019
Global Investor Forum Contact
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

Madam Therapeutics

Next Generation Antibiotics to fight Antimicrobial Resistance

Madam Therapeutics is an “end of pre-clinical stage” biotech company that develops antibiotics with a novel Mechanism of action. The company managed to acquire substantial funding (€ 9.2M) by own investments, grants and donations, which led to successful finalization of the pre-clinical stage research of its lead product SAAP-148. Recently a first seed equity investment round of €1.1M was closed successfully. The company is now ready to enter into the clinical proof of concept stage. Madam Therapeutics is currently raising funds to start the preparation of the next clinical stages in 2019. After the phase I/IIa clinical study, Madam Therapeutics aims to out-license the product(s) to a larger a pharma company for further development and commercialisation.

Speaker: Leonie de Best, Chief Business Officer

Leonie de Best is Chief Business Officer at Madam Therapeutics. She has a background in Analytical Chemistry and has 20 years of extensive management experience in biotech/life science industry, of which 5 years at senior executive level (COO). Leonie has a broad experience in the management of business processes in the field of (in-vitro) diagnostic assay and pharmaceutical product development from research stage until European and US market registrations.
Join the VIP CEO-Investor dinner

Are you a CEO or an investor and interested to network with high level delegates during our special VIP CEO-Investor evening programme and dinner? Book your tickets now!  Register here

Join the VIP CEO-Investor dinner!
Watch our brand new teaser!

The teaser of Innovation for Health 2019 is online now, including highlights of keynote speakers, sessions and themes.
Watch the new teaser film of Innovation for Health to get an impression of what you can expect.

Like what you see? Share it via social media and get a discount of €50 on your registration fee.
Watch the teaser

Teaser Innovation for Health 2019
Selected start-up pitches

An exciting part of the programme is the yearly start-up pitch contest. Ten start-up companies will get the opportunity to pitch their company and healthcare innovation to key players and decision makers in Health & Life sciences sector on 14 February at Innovation for Health and Global Investor Forum! Find out who is selected to compete in the yearly start-up pitch contest!
Check it here!

Join the Design Expo!
Sponsors & Partners
Main partner
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Award sponsor
AXON Lawyers
Award sponsor
Vereniging Innovatieve Geneesmiddelen
Global Investor Forum
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.